Brief: Valeo Pharma Reports Record Quarterly Revenues For The Q1 2023
15/03/2023 21:02
March 15 (Reuters) - Valeo Pharma Inc VPH.TO :
* VALEO PHARMA REPORTS RECORD QUARTERLY REVENUES FOR THE
FIRST
QUARTER 2023
* VALEO PHARMA INC Q1 REVENUE ROSE 210 PERCENT TO C$13.2
MILLION
* VALEO PHARMA INC - NET LOSS WAS $6.2 MILLION FOR QUARTER
ENDED
JANUARY 31, 2023 COMPARED TO $5.9 MILLION FOR QUARTER ENDED
JANUARY 31, 2022
Source text for Eikon: ID:nCNWLKPbra
Further company coverage: VPH.TO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Valeo Pharma
See all newsBrief: Valeo Pharma Says Co Initiates Restructuring Proceedings
Brief: Valeo Pharma Amends Credit Facility With Sagard Healthcare Royalty Partners
Brief: Valeo Pharma Announces Restructuring Of Commercial Field Operations To Support Path To Profitability
Brief: Valeo Pharma Announces Appointment Of Mr. Al Moghaddam To Board Of Directors
Brief: Valeo Pharma Amends Agreement With Novartis Pharmaceuticals Canada